Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Some new stuff from the FDA.
Would AGN's EOP2 meeting for guidance on the Phase 3 design or endpoints be involved?
It seems the Ifenprodil CT covered most of this guidance already.
Maybe this gives AGN latitude to participate in a Sponsor's 'Master protocol' and it also may make it easier for a BP to incorporate Ifenprodil into a 'cocktail' approach.?.
Sure seems like there is still Strong support from the FDA for COVID drug Clinical Trials. At the least...GLTA...

https://www.fda.gov/media/148739/download